Background: Successful bone engineering requires an understanding of the effects of mechanical stress on osteoblast differentiation. Therefore, we examined the effects of varying magnitude and duration of fluid shear stress on factors associated with osteoblastic differentiation.
Methods: Using a cone viscometer, primary neonatal rat calvarial osteoblasts were exposed to continuous fluid shear stress at varying doses: 0.21, 0.43, and 0.85 Pa for varying time periods. Gene expression was analyzed using Northern blots and nitric oxide production was quantified with the colorimetric Griess reaction.
Results: Fluid shear stress stimulated comparable transient increases in TGF-β1 and TGF-β3 expression by 3 hours. TGF-β1 expression returned to baseline by 12 hours at all shear doses. In contrast, TGF-β3 expression decreased by 22 percent and 47 percent at 12 hours in response to 0.43 Pa and 0.85 Pa, respectively. Osteopontin and Msx-2 expression patterns were consistent with a more differentiated phenotype at all shear levels. The maximum level of shear stress increased nitric oxide production 2.5-fold at 12 hours and 6.0-fold at 24 hours.
Conclusions: These data demonstrate differential regulation of TGF-β1 and TGF-β3 isoforms with fluid shear stress. Furthermore, because osteopontin and Msx-2 changes were consistent with progressive differentiation at all levels of shear stress, dosage appears to be less important than the presence of an effective physical stimulus. Lastly, nitric oxide does not appear to be the primary regulator of early transcriptional changes found in this study.
Stanford, Calif.; and New York, N.Y.
From the Department of Surgery and the Orthopaedic Research Laboratory, Stanford University School of Medicine; and the Institute of Reconstructive Plastic Surgery, New York University Medical Center.
Received for publication October 2, 2007; accepted February 20, 2008.
The first two authors contributed equally to this work.
Disclosure: None of the authors has any financial disclosures to make or any conflicts of interest to disclose.
R. Lane Smith, Ph.D., Orthopaedic Research Laboratory, R105, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, Calif. 94305-5341, email@example.com